An appellate court is expected to rule any day in a major whistleblower case.
The decision could reshape how the False Claims Act is enforced and might even reach the Supreme Court.
For nursing facilities long burdened by these cases, optimism is understandable. But caution remains warranted.
The case, United States ex rel. Zafirov v. Florida Medical Associates, examines whether private whistleblowers can pursue fraud claims on the government’s behalf. In 2024, a District Court said no.
Does that translate to less trouble for providers? Depends on how you define less trouble.
Even if courts continue to limit qui tam actions, enforcement won’t disappear — it will simply take a more deliberate, targeted form. Frivolous claims may persist, but when cases do move forward, the stakes will likely be higher.
In practical terms, your exposure won’t hinge on who files a case. It will depend on whether your billings align with your documentation — and whether that documentation accurately reflects the care delivered.
That sounds straightforward, but many operators know how quickly operational challenges can gum up the works.
Staffing gaps, delayed charting, and MDS upcoding — even if no harm is intended — can all create problems. Small errors or inconsistencies can still draw scrutiny and raise unexpected questions. Put more bluntly: claims problems start in your building, not the courtroom.
What will continue to matter most is how your operation holds up under scrutiny —...
An appellate court is expected to rule any day in a major whistleblower case. The decision could reshape how the False Claims Act is enforced and might even reach the Supreme Court. For nursing fa...